My theory, is that it was in the design to have both trials completed at the same time.
As I understand both trials have multipurpose usage.
BTX1701 is supposed to have greater concentration and improved quality control.
And BTX1204A is a new delivery method for Permetrex.
Therefore, the timing of these results are imperative to the continuation of trials for BTX1503 and BTX1801.
But then again, I'm a half glass full kind of guy.
My theory, is that it was in the design to have both trials...
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $633.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 101 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 34.0¢ | 1503 | 1 |
View Market Depth
| Last trade - 09.23am 30/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |
Day chart unavailable